You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 24, 2024

Patent: 9,950,039

✉ Email this page to a colleague

« Back to Dashboard

Summary for Patent: 9,950,039

Title:	Insulin glargine/lixisenatide fixed ratio formulation
Abstract:	The present invention refers to a pharmaceutical composition comprising (a) lixisenatide or/and a pharmaceutically acceptable salt thereof, and (b) insulin glargine or/and a pharmaceutically acceptable salt thereof, wherein the compound (b) and compound (a) are present in a fixed ratio.
Inventor(s):	Souhami; Elisabeth (Paris, FR), Silvestre; Louise (Paris, FR)
Assignee:	SANOFI-AVENTIS DEUTSCHLAND GMBH (Frankfurt am Main, DE)
Application Number:	14/965,586
Patent Claims:	see list of patent claims

Details for Patent 9,950,039

Glossary

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Sanofi-aventis U.s. Llc	LANTUS	insulin glargine	Injection	021081	04/20/2000	⤷ Try a Trial	2034-12-12
Sanofi-aventis U.s. Llc	LANTUS	insulin glargine	Injection	021081	04/25/2007	⤷ Try a Trial	2034-12-12
Eli Lilly And Company	BASAGLAR	insulin glargine	Injection	205692	12/16/2015	⤷ Try a Trial	2034-12-12
Eli Lilly And Company	BASAGLAR	insulin glargine	Injection	205692	11/15/2019	⤷ Try a Trial	2034-12-12
Sanofi-aventis U.s. Llc	ADLYXIN	lixisenatide	Injection	208471	07/27/2016	⤷ Try a Trial	2034-12-12
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Approval Date	>Patent No.	>Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.